Close Menu

NEW YORK (GenomeWeb) – ArcherDx announced today that it has partnered with Germany-based Merck KGaA to develop and commercialize a next-generation sequencing-based companion diagnostic assay for one of the pharmaceutical company's drug candidates.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.